Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silversulfadiazine cream containing EGF for second-degree burn wound healing
IRCT20220424054633N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2022
- Modality
- Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of epidermal growth factor + silver sulfadiazine in burn injury, sponsored by Tehran University of Medical Sciences. Started Jun 2022; status: completed.
02
Drugs
epidermal growth factor + silver sulfadiazine
03
Conditions
burn injury
Beyond the preview
Go deeper on IRCT20220424054633N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220424054633N1.